Resources

×

Spotlight Resources

Videos

Analytics Product Overview

Gain comprehensive insight into formulary and medical benefit coverage, covered lives, and policy and restriction information.

Market Access Downloads

Ulcerative Colitis

MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.

Infographics

Understand Your Specialty Pharmacy’s Performance

Struggling to capture your organization’s performance? Learn how MMIT can provide unblinded feedback to help guide decision-making with our Satisfaction Surveys.

Infographics

Why MMIT’s Lab Data?

Open to learn why MMIT’s Lab Data is the best solution for longitudinal tracking of patients.

Infographics

How to Stop Losing Money...

Contracting in pharma has grown increasingly complex, which results in significant rebate leakage for manufacturers. Recent MMIT research highlights the severity of the problem.

Case Studies

From Impasse to Insights: Finding...

Learn how pharma companies that were early adopters of MMIT’s FormTrak integration in Veeva CRM see the new functionality changing their workflow.

Playbooks

Patient Support Programs

Patient assistance programs can have an enormous impact on the time-to-treatment for prescribers and patients. Your ability to establish a patient assistance program strategy, especially when there are barriers to prescribing.

Product Brochures

RC Claim Assist

Learn more about MMIT’s RC Claim Assist solution.

Market Access Downloads

Acute Myeloid Leukemia

MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.

Messaging Playbooks

Monitor Payer Messaging Perception: Oncology...

In addition to outlining five ways to optimize your message strategy and drive sales, this playbook also includes real messages and payer reactions in oncology biosimilars.

Messaging Playbooks

Monitor Payer Messaging Perception: Atopic...

In addition to outlining five ways to optimize your message strategy and drive sales, this playbook also includes real messages and payer reactions in atopic dermatitis.

Messaging Playbooks

Monitor Payer Messaging Perception: Non-Small...

In addition to outlining five ways to optimize your message strategy and drive sales, this playbook also includes real messages and payer reactions in non-small cell lung cancer.

Messaging Playbooks

Monitor Payer Messaging Perception: Migraine

In addition to outlining five ways to optimize your message strategy and drive sales, this playbook also includes real messages and payer reactions in migraine.

Messaging Playbooks

Monitor Payer Messaging Perception: Rheumatoid...

In addition to outlining five ways to optimize your message strategy and drive sales, this playbook also includes real messages and payer reactions in rheumatoid arthritis.

Messaging Playbooks

Monitor Payer Messaging Perception: Breast...

In addition to outlining five ways to optimize your message strategy and drive sales, this playbook also includes real messages and payer reactions in breast cancer.

Product Brochures

Rapid Response

Learn more about MMIT’s Rapid Response solution.

Product Brochures

MMIT Engage

Learn more about MMIT’s Engage solution.

Videos

30-40% of Medical Drug Claims...

Videos

RC Claim Assist for Pharma...

Webinars

Meet the Expert: Addressing Rebate...

Learn the causes of rebate leakage and how MMIT’s Contract Validation solution can provide a workflow automation platform that enables manufacturers to validate formulary positioning at scale.

Infographics

NDC Mandate Management

RJ Health, an MMIT company, conducted a survey on NDC mandates. In 2016 and 2021, we asked payers questions such as how they are managing NDCs and who performs unit conversions. We compiled these results

Market Access Downloads

Psoriasis

MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.

Market Access Downloads

Atopic Dermatitis

MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.

Market Access Downloads

Non-Small Cell Lung Cancer

MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.

Market Access Downloads

Multiple Sclerosis

MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.

Product Brochures

Bridging as a Service

Learn more about MMIT’s Bridging as a Service solution.

Product Brochures

Clinical Lab Data

Inform site selection, drive trial awareness and enrollment, and uncover patient-centric signals for evidence generation and outcomes studies.

Market Access Downloads

Rheumatoid Arthritis

MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.

Case Studies

MMIT’s Strategic Partnership: Rapid Response...

How MMIT’s longstanding advisory relationship with a global pharmaceutical company helped transform its portfolio strategy.

Indication Brief Excerpts

Metastatic Melanoma

This excerpt gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.

Videos

Healthcare Frustrations

Understanding and maintaining insight into payer enrollment is difficult. At MMIT, we are focused on helping our clients understand the complex payer landscape.

Videos

MMIT Executive Viewpoint: Chris Webb

How Medical Billing and Coding Can Impact Patient Access. Hear from the experts from RJ Health, an MMIT company.

Indication Brief Excerpts

Non-Small Cell Lung Cancer

This excerpt gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.

Indication Brief Excerpts

Bladder Cancer

This excerpt gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.

Indication Brief Excerpts

Breast Cancer

This excerpt gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.

Product Brochures

Commercial Lab Data

Learn more about MMIT’s proactive, economic, precise, and comprehensive solution that can help manufacturers promote their therapies to specific providers using lab test results before a diagnosis and/or prescribing decision is made.

Indication Brief Excerpts

Orphan Diseases

This excerpt gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.

Market Access Downloads

Prostate Cancer

MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.

Market Access Downloads

Diabetes

MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.

Market Access Downloads

Crohn’s Disease

MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.

Market Access Downloads

Multiple Myeloma

MMIT’s Market Access Downloads combine payer perceptions from Message Monitor and coverage data from Analytics.

Case Studies

Strategic Launch Report With In-Depth...

Learn how a pharma company leveraged MMIT’s Strategic Launch Report combined with In-Depth Interviews to get a unique view into the market access path for its therapy.

Indication Brief Excerpts

Multiple Sclerosis

This excerpt gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.

Indication Brief Excerpts

Rheumatoid Arthritis

This excerpt gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.

Product Brochures

Surveillance

Learn more about MMIT’s Surveillance solution.

Product Brochures

PULSE Provider Analytics

PULSE Provider includes clinical pathway information for IDNs that create and maintain their own pathways.

Product Brochures

PULSE Pathways Analytics

PULSE Pathways includes data on third parties that develop pathways for IDNs and payers.

Infographics

Analyzing the Patient Journey

Learn how Patient Access Analytics from MMIT and Panalgo can show how coverage decisions influence physician prescriber behavior.

Webinars

Meet the Expert: Pathways Utilization...

Learn how a product’s placement on pathways affects its utilization and uptake, and ultimately, patient’s access to life saving therapies.

Webinars

Meet the Expert: Understanding the...

Explore how we can expect the market to react and how factors such as launch timing, interchangeability, and contracting will shape the immunology landscape.

Indication Brief Excerpts

Colorectal Cancer

This excerpt gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.

Product Brochures

Patient Access Analytics

Read a summary of the Patient Access Analytics solution from MMIT and Panalgo.

P&T Sessions

Immunology Biosimilars: Webcast

MMIT recently held a syndicated 90-minute Webcast including the key faculty from our P&T panel, alongside key physician experts.

P&T Sessions

Ulcerative Colitis

MMIT recently held a syndicated, simulated P&T session focused on the approvals of mirikizumab and filgotinib, and the launch of Amjevita (biosimilar Humira).

P&T Sessions

How Will Existing Contracts With...

P&T Session Immunology Biosimilars: MMIT recently held a syndicated 90-minute Webcast including the key faculty from our P&T panel, alongside key physician experts.

P&T Sessions

How Do Payers See The...

P&T Session Immunology Biosimilars: MMIT recently held a syndicated 90-minute Webcast including the key faculty from our P&T panel, alongside key physician experts.

P&T Sessions

Could Manufacturers Entice Payers to...

P&T Session Immunology Biosimilars: MMIT recently held a syndicated 90-minute Webcast including the key faculty from our P&T panel, alongside key physician experts.

P&T Sessions

How Will Portfolio Contracting Impact...

P&T Session Immunology Biosimilars: MMIT recently held a syndicated 90-minute Webcast including the key faculty from our P&T panel, alongside key physician experts.

P&T Sessions

How Will The Existence Of...

P&T Session Ulcerative Colitis: MMIT recently held a syndicated, simulated P&T session focused on the approvals of mirikizumab and filgotinib, and the launch of Amjevita (biosimilar Humira).

P&T Sessions

As New Entrants Prepare To...

P&T Session Ulcerative Colitis: MMIT recently held a syndicated, simulated P&T session focused on the approvals of mirikizumab and filgotinib, and the launch of Amjevita (biosimilar Humira).

P&T Sessions

How Does The Impending Launch...

P&T Session Ulcerative Colitis: MMIT recently held a syndicated, simulated P&T session focused on the approvals of mirikizumab and filgotinib, and the launch of Amjevita (biosimilar Humira).

P&T Sessions

How Will The Complexity Of...

P&T Session Ulcerative Colitis: MMIT recently held a syndicated, simulated P&T session focused on the approvals of mirikizumab and filgotinib, and the launch of Amjevita (biosimilar Humira).

Case Studies

Helping MarketLauncher Capture Success

Learn how MMIT and MarketLauncher helped a medtech company engage a difficult-to-reach health plan audience.

Product Brochures

Navigator

Learn more about MMIT’s Formulary Navigator solution.

Infographics

Payer Intelligence Toolkit

You need a variety of resources to develop a successful payer strategy. Download our infographic to learn how MMIT can help your organization.

Indication Brief Excerpts

Multiple Myeloma

This excerpt gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.

Case Studies

Credibility’s Competitive Advantage

Learn how RJ Health helped a niche healthcare company bolster its payer communications.

Case Studies

A Second-to-Market Success

Learn how a data-driven market access strategy and competitor benchmarking led to launch excellence.

Case Studies

Analytics Data Helps Healthcare Services...

Learn how a healthcare services company partnered with MMIT to help support its provider network with coverage data.

Product Brochures

Contract Validation

Contract Validation is a workflow automation platform that enables manufacturers to validate formulary positioning at scale by crosschecking the contract language against MMIT’s industry-leading data.

Webinars

Meet the Expert: MMIT’s FormTrak...

MMIT’s FormTrak tool helps prescribers get their patients on the right therapy even amid complex drug coverage requirements. FormTrak’s integration in Veeva CRM, pharma field teams can deliver an access message right in Veeva’s platform.

Videos

MMIT’s Integration in Veeva CRM:...

Learn more about how MMIT’s FormTrak solution can help your team.

Videos

MMIT’s Integration in Veeva CRM:...

Learn more about how MMIT’s FormTrak solution can help your team.

Videos

MMIT’s Integration in Veeva CRM:...

Learn more about how MMIT’s FormTrak solution can help your team.

Indication Brief Excerpts

Prostate Cancer

This excerpt gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.

P&T Sessions

Atopic Dermatitis

MMIT recently held a syndicated simulated P&T session focused on the approvals of ruxolitinib cream (Opzelura), lebrikizumab, and tralokinumab for atopic dermatitis.

P&T Sessions

How will the JAK inhibitor...

P&T Session Atopic Dermatitis: MMIT recently held a syndicated simulated P&T session focused on the approvals of ruxolitinib cream (Opzelura), lebrikizumab, and tralokinumab for atopic dermatitis.

P&T Sessions

How does the P&T committee...

P&T Session Atopic Dermatitis: MMIT recently held a syndicated simulated P&T session focused on the approvals of ruxolitinib cream (Opzelura), lebrikizumab, and tralokinumab for atopic dermatitis.

P&T Sessions

How do the dermatologist perceive...

P&T Session Atopic Dermatitis: MMIT recently held a syndicated simulated P&T session focused on the approvals of ruxolitinib cream (Opzelura), lebrikizumab, and tralokinumab for atopic dermatitis.

P&T Sessions

How does the launch of...

P&T Session Atopic Dermatitis: MMIT recently held a syndicated simulated P&T session focused on the approvals of ruxolitinib cream (Opzelura), lebrikizumab, and tralokinumab for atopic dermatitis.

P&T Sessions

How will contracting impact formulary...

P&T Session Atopic Dermatitis: MMIT recently held a syndicated simulated P&T session focused on the approvals of ruxolitinib cream (Opzelura), lebrikizumab, and tralokinumab for atopic dermatitis.

Informational

How Will MMIT’s FormTrak Integration...

MMIT’s new FormTrak integration in Veeva CRM changes how pharma companies detail healthcare providers. Now your field teams can access FormTrak seamlessly within Veeva thanks to the first native market access integration.

Case Studies

Drug Launch Planning: Using Analytics...

Learn how a small pharma company leveraged MMIT’s Analytics platform to drive its messaging with healthcare providers as it launched its first commercial product at the start of the COVID-19 pandemic.

Product Brochures

FormTrak & Veeva

Learn more about MMIT’s FormTrak integration with Veeva CRM.

Indication Brief Excerpts

Diabetes

This excerpt gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.

Case Studies

Post-Launch Tracking Surveys

Learn how a pharma company partnered with MMIT’ to understand payer perceptions of its brand over time as competitors enter the market.

Case Studies

Value Proposition Message Testing

Learn how a pharma company preparing for a drug launch partnered with MMIT to gain insight into the most effective messaging with payers.

Webinars

Meet the Expert: Navigating the...

Understanding a large complex payer and their subsidiaries to segment your contracting plan or recognizing lives enrollment shifts in specific geographies, having payer data source solution to support your sales and marketing team is crucial.

Webinars

Meet the Expert: Tracking Access...

Payer coverage policies continue to become more complex with increasing access hurdles. Dig into ways to sift through the noise and uncover payer account intervention and pull-through opportunities via dashboards and real-time alerts.

Informational

Tips to Engage Pharma Manufacturers

Without the right tools, your account managers will face many obstacles trying to win more pharma business. We’ll give you our top tips on how to engage with pharma manufacturers and differentiate your organization.

P&T Sessions

Neutropenia

MMIT’s P&T Persectives on Neutropenia reviewed Rolontis® (eflapegrastim), a new long-acting rhG-CSF therapy for patients with chemotherapy induced neutropenia.

P&T Sessions

Financial considerations for Rolontis® (Contracting...

MMIT’s P&T Persectives on Neutropenia reviewed Rolontis® (eflapegrastim), a new long-acting rhG-CSF therapy for patients with chemotherapy induced neutropenia.

P&T Sessions

What shifts have been observed...

MMIT’s P&T Persectives on Neutropenia reviewed Rolontis® (eflapegrastim), a new long-acting rhG-CSF therapy for patients with chemotherapy induced neutropenia.

P&T Sessions

Does Neulasta® Onpro® retain any...

MMIT’s P&T Persectives on Neutropenia reviewed Rolontis® (eflapegrastim), a new long-acting rhG-CSF therapy for patients with chemotherapy induced neutropenia.

P&T Sessions

Oncologist reactions to Rolontis®. Is...

MMIT’s P&T Persectives on Neutropenia reviewed Rolontis® (eflapegrastim), a new long-acting rhG-CSF therapy for patients with chemotherapy induced neutropenia.

Webinars

Meet the Expert: Advances in...

Learn how formularies are currently managed, examine some of the key challenges faced by payers and PBMs, and evaluate new integrated solutions to optimize management of both pharmacy and medically covered drugs.

Case Studies

Advisory Board Meetings

Learn how a pharma company leveraged MMIT’s advisory board service to get unique insights from payers and physician key opinion leaders (KOLs) to support its drug launch.

Case Studies

Custom Pricing and Contracting Studies

Learn how a pharma company’s market access team leveraged MMIT’s quantitative online surveys to obtain a custom pricing and contracting study to support its drug launch.

Webinars

Meet the Expert: Predicting Enrollment...

Factors complicate the payer enrollment landscape, making it challenging to project membership rolls across payers, geographies and channels. See enrollment projections, the drivers behind them and what you can expect from the 2021 payer landscape.

Case Studies

Prepare For a Device Launch

Learn how a medical device company partnered with and leveraged MMIT’s Payer Landscape data.

Webinars

Meet the Expert: Medical Reimbursement/...

Learn how claims reimbursement is currently being managed, as well as some best practices for leveraging specialty drug data to streamline the process.

Case Studies

Breaking Down Granular Enrollment Data

Learn how a healthcare IT organization was able to gain a deeper understanding of their market potential and obtain competitive intelligence with Payer Landscape.

Case Studies

Systematizing Health Plan Targeting

Learn how a healthcare IT organization automated payer account identification and outreach.

Case Studies

Understanding PBM Competitive Intelligence

Take a look into how a PBM was able to gain a deeper understanding of their market potential and obtain competitive intelligence with Payer Landscape.

P&T Sessions

Non-Small Cell Lung Cancer

Syndicated IDN P&T session focused on the entry of two new medications; capmatinib (Tabrecta) from Novartis, and tepotinib from Merck. Indicated for the treatment of adult patients with METex14 skipping mutation NSCLC.

P&T Sessions

Is there a product that...

P&T Session NSCLC: Syndicated IDN P&T session focused on the entry of two new medications; capmatinib (Tabrecta) from Novartis, and tepotinib from Merck. Indicated for the treatment of adult patients with METex14 skipping mutation NSCLC.

P&T Sessions

Introduction into scenario 1 pricing

P&T Session NSCLC: Syndicated IDN P&T session focused on the entry of two new medications; capmatinib (Tabrecta) from Novartis, and tepotinib from Merck. Indicated for the treatment of adult patients with METex14 skipping mutation NSCLC.

P&T Sessions

Oncologist’s opinion on the drugs...

P&T Session NSCLC: Syndicated IDN P&T session focused on the entry of two new medications; capmatinib (Tabrecta) from Novartis, and tepotinib from Merck. Indicated for the treatment of adult patients with METex14 skipping mutation NSCLC.

P&T Sessions

Question posed by non-Oncologist P&T...

P&T Session NSCLC: Syndicated IDN P&T session focused on the entry of two new medications; capmatinib (Tabrecta) from Novartis, and tepotinib from Merck. Indicated for the treatment of adult patients with METex14 skipping mutation NSCLC.

White Papers

Insurer, Specialty Pharmacy Rely on...

As specialty pharmaceuticals consume an ever-larger share of healthcare benefit dollars, payers, providers and other healthcare organizations are realizing the importance of managing drugs administered under the medical benefit, which most often are specialty drugs.

Webinars

Meet the Expert: Access Trends...

Access barriers to the use of innovative technology such as administrative burden and reimbursement challenges. We will also touch upon payer concern about costs which might be underlying these issues.

Webinars

Meet the Expert: Predicting Payer...

Learn when and how to select the right analogs to set the most accurate expectations and payer strategy at launch.

Infographics

Payer Profile Sample: Payer

Access dozens of payer profiles and in-depth narratives, focused on top health plans, PBMs and all 50 U.S. states.

Infographics

Payer Profile Sample: PBM

Access dozens of payer profiles and in-depth narratives, focused on top health plans, PBMs and all 50 U.S. states.

Infographics

Payer Profile Sample: State

Access dozens of payer profiles and in-depth narratives, focused on top health plans, PBMs and all 50 U.S. states.

White Papers

Patient Access During Pre-Launch Phases

Why aren’t pharma teams shifting market access strategies to earlier phases of drug development? The influence of payers and PBMs is often poorly understood.

Case Studies

Streamlining the Referral Process

Take a look into how a specialty pharmacy partnered with MMIT to enhance its referral process and decrease time to therapy for patients.

P&T Sessions

Heart Failure

MMIT recently conducted a syndicated simulated P&T Heart Failure session focused on the entry Farxiga, and anticipated entry of Jardiance, into heart failure.

P&T Sessions

Would Payers be Willing to...

P&T Session Heart Failure:  MMIT recently conducted a syndicated simulated P&T Heart Failure session focused on the entry Farxiga, and anticipated entry of Jardiance, into heart failure.

P&T Sessions

Is Entresto at Risk From...

P&T Session Heart Failure:  MMIT recently conducted a syndicated simulated P&T Heart Failure session focused on the entry Farxiga, and anticipated entry of Jardiance, into heart failure.

P&T Sessions

Are the Heart Failure Benefits...

P&T Session Heart Failure:  MMIT recently conducted a syndicated simulated P&T Heart Failure session focused on the entry Farxiga, and anticipated entry of Jardiance, into heart failure.

P&T Sessions

What is a Cardiologist’s Perspective...

P&T Session Heart Failure:  MMIT recently conducted a syndicated simulated P&T Heart Failure session focused on the entry Farxiga, and anticipated entry of Jardiance, into heart failure.

Videos

Unlock the Power of Account...

View a demo of the Payer Landscape tool.

Indication Brief Excerpts

Migraine

This excerpt gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.

Indication Brief Excerpts

Atopic Dermatitis

This excerpt gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.

Indication Brief Excerpts

CAR-T

This excerpt gives a sneak preview of the report, which combines in-depth narratives with data-rich charts to provide current insights about a single indication, sourced from the industry-leading Biologics and Oncology Indices.

Title

Description